Docetaxel as neo-adjuvant therapy for radically treatable stage III non-small cell lung cancer: early results of an international phase III study
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference11 articles.
1. Induction chemotherapy for NSCLC: a consensus report;Klatersky;Lung Cancer,1991
2. The role of induction (neo-adjuvant) chemotherapy in stage IIIA NSCLC;Rosell;Chest,1996
3. Benefits of neo-adjuvant chemotherapy in NSCLC;Pastorino;Chest,1996
4. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials;Br. Med. J.,1995
5. Phase II study of docetaxel for recurrent or metastatic non-small cell lung cancer;Fossella;J. Clin. Oncol.,1994
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Neoadjuvant Treatments in Resectable Non-small Cell Lung Cancer;Malignant Tumors of the Lung;2004
2. Combined Modality Treatment of Non-Small-Cell Lung Cancer;American Journal of Respiratory Medicine;2003-12
3. Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non–Small-Cell Lung Cancer: A Multicenter Phase II Trial;Journal of Clinical Oncology;2003-05-01
4. Docetaxel as neoadjuvant therapy for radically treatablestage III non-small-cell lung cancer: a multinational randomised phase III study;Annals of Oncology;2003-01
5. Non-Small Cell Lung Cancer;Oncologic Therapies;2003
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3